Lv6
1750 积分 2023-07-02 加入
Immune-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors: A real-world pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database (2014–2022)
23天前
已完结
Identifying cardiovascular toxicity associated with sphingosine 1-phosphate receptor modulators: A case-control study based on the FDA adverse event reporting system
23天前
已完结
Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire
2个月前
已完结
Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients with Fibrotic Interstitial Lung Disease
2个月前
已完结
Development and Validation of a Clinical, CT, Genomic Classifier and BAL Scoring System for Diagnosing IPF
2个月前
已完结
Pharmacovigilance insights into medication-induced risk of dural arteriovenous fistula
3个月前
已完结
Reported Psychiatric Adverse Events Among Isotretinoin Users: Monitoring Priorities from a 20-Year FAERS Database Study
3个月前
已完结
Post-marketing safety evaluation of Vortioxetine: A decade-long pharmacovigilance study based on the FAERS database
3个月前
已完结
Detection of risk signals for ustekinumab in the real world using the FDA adverse event reporting system (FAERS)
3个月前
已完结
The safety assessment of ustekinumab on psoriasis and psoriatic arthritis: A real-world analysis based on the FDA adverse event reporting system database
3个月前
已完结
皖公网安备34019202002308
